Together, results from Fig. 8A–D of mouse lung tumor model studies confirmed our in vitro results showing that ERα can play a positive role in promoting NSCLC progression via altering the CCR2‐ and CXCR4‐involved pathways. Here, CCR2 is linked to non-small cell lung carcinoma.